Astrocytic modulation of excitatory synaptic signaling in a mouse model of Rett syndrome

Benjamin Rakela, Paul Brehm, Gail Mandel

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Studies linking mutations in Methyl CpG Binding Protein 2 (MeCP2) to physiological defects in the neurological disease, Rett syndrome, have focused largely upon neuronal dysfunction despite MeCP2 ubiquitous expression. Here we explore roles for astrocytes in neuronal network function using cortical slice recordings. We find that astrocyte stimulation in wild-type mice increases excitatory synaptic activity that is absent in male mice lacking MeCP2 globally. To determine the cellular basis of the defect, we exploit a female mouse model for Rett syndrome that expresses wild-type MeCP2-GFP in a mosaic distribution throughout the brain, allowing us to test all combinations of wild-type and mutant cells. We find that the defect is dependent upon MeCP2 expression status in the astrocytes and not in the neurons. Our findings highlight a new role for astrocytes in regulation of excitatory synaptic signaling and in the neurological defects associated with Rett syndrome.

Original languageEnglish (US)
Article numbere31629
JournaleLife
Volume7
DOIs
StatePublished - Jan 9 2018

Fingerprint

Methyl-CpG-Binding Protein 2
Rett Syndrome
Astrocytes
Modulation
Defects
Neurons
Brain
Mutation

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Astrocytic modulation of excitatory synaptic signaling in a mouse model of Rett syndrome. / Rakela, Benjamin; Brehm, Paul; Mandel, Gail.

In: eLife, Vol. 7, e31629, 09.01.2018.

Research output: Contribution to journalArticle

@article{1ed72eca1a1f462cba215d0494106c33,
title = "Astrocytic modulation of excitatory synaptic signaling in a mouse model of Rett syndrome",
abstract = "Studies linking mutations in Methyl CpG Binding Protein 2 (MeCP2) to physiological defects in the neurological disease, Rett syndrome, have focused largely upon neuronal dysfunction despite MeCP2 ubiquitous expression. Here we explore roles for astrocytes in neuronal network function using cortical slice recordings. We find that astrocyte stimulation in wild-type mice increases excitatory synaptic activity that is absent in male mice lacking MeCP2 globally. To determine the cellular basis of the defect, we exploit a female mouse model for Rett syndrome that expresses wild-type MeCP2-GFP in a mosaic distribution throughout the brain, allowing us to test all combinations of wild-type and mutant cells. We find that the defect is dependent upon MeCP2 expression status in the astrocytes and not in the neurons. Our findings highlight a new role for astrocytes in regulation of excitatory synaptic signaling and in the neurological defects associated with Rett syndrome.",
author = "Benjamin Rakela and Paul Brehm and Gail Mandel",
year = "2018",
month = "1",
day = "9",
doi = "10.7554/eLife.31629",
language = "English (US)",
volume = "7",
journal = "eLife",
issn = "2050-084X",
publisher = "eLife Sciences Publications",

}

TY - JOUR

T1 - Astrocytic modulation of excitatory synaptic signaling in a mouse model of Rett syndrome

AU - Rakela, Benjamin

AU - Brehm, Paul

AU - Mandel, Gail

PY - 2018/1/9

Y1 - 2018/1/9

N2 - Studies linking mutations in Methyl CpG Binding Protein 2 (MeCP2) to physiological defects in the neurological disease, Rett syndrome, have focused largely upon neuronal dysfunction despite MeCP2 ubiquitous expression. Here we explore roles for astrocytes in neuronal network function using cortical slice recordings. We find that astrocyte stimulation in wild-type mice increases excitatory synaptic activity that is absent in male mice lacking MeCP2 globally. To determine the cellular basis of the defect, we exploit a female mouse model for Rett syndrome that expresses wild-type MeCP2-GFP in a mosaic distribution throughout the brain, allowing us to test all combinations of wild-type and mutant cells. We find that the defect is dependent upon MeCP2 expression status in the astrocytes and not in the neurons. Our findings highlight a new role for astrocytes in regulation of excitatory synaptic signaling and in the neurological defects associated with Rett syndrome.

AB - Studies linking mutations in Methyl CpG Binding Protein 2 (MeCP2) to physiological defects in the neurological disease, Rett syndrome, have focused largely upon neuronal dysfunction despite MeCP2 ubiquitous expression. Here we explore roles for astrocytes in neuronal network function using cortical slice recordings. We find that astrocyte stimulation in wild-type mice increases excitatory synaptic activity that is absent in male mice lacking MeCP2 globally. To determine the cellular basis of the defect, we exploit a female mouse model for Rett syndrome that expresses wild-type MeCP2-GFP in a mosaic distribution throughout the brain, allowing us to test all combinations of wild-type and mutant cells. We find that the defect is dependent upon MeCP2 expression status in the astrocytes and not in the neurons. Our findings highlight a new role for astrocytes in regulation of excitatory synaptic signaling and in the neurological defects associated with Rett syndrome.

UR - http://www.scopus.com/inward/record.url?scp=85042076058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042076058&partnerID=8YFLogxK

U2 - 10.7554/eLife.31629

DO - 10.7554/eLife.31629

M3 - Article

VL - 7

JO - eLife

JF - eLife

SN - 2050-084X

M1 - e31629

ER -